The Role of Anti-HSV Therapeutics in the HIV-infected Host and in Controlling the HIV Epidemic

Authors: Barton, Simon1; Celum, Connie2; Schacker, Timothy W.3

Source: Herpes, Volume 12, Number 1, 2005 , pp. 15-22(8)

Publisher: Cambridge Medical Publications

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

The management of genital herpes in patients co-infected with human immunodeficiency virus (HIV) varies considerably from those without HIV infection. The International Herpes Management Forum (IHMF®) has published guidelines for the diagnosis and management of herpes simplex virus (HSV) infection in the HIV-infected host. In 2004, these recommendations were supplemented after consideration of the most recent research conducted in this field, which adds to the growing body of evidence linking the epidemics of HSV-2 and HIV-1 infection. This article presents the supporting evidence for these recommendations and statements. Recent studies suggest that HSV-2 infection may elevate viral load during HIV-1 infection and hence lead to accelerated disease progression. It therefore seems logical to offer suppressive antiviral therapy routinely to HIV-positive patients. This approach is supported by studies demonstrating the safety and efficacy of HSV antiviral therapy in individuals co-infected with HSV and HIV. The question remains whether HSV antiviral therapeutics reduce the risk of HIV acquisition and transmission. Clinical trials are being conducted to address this question. HSV type-specific serological testing is warranted in those who are infected with, or who are at high risk of acquiring, HIV infection. However, in developing countries and resource-poor settings, their utility is less clear for a number of reasons. These aspects are also discussed.

Keywords: HERPES SIMPLEX VIRUS; HUMAN IMMUNODEFICIENCY SYNDROME; TRANSMISSION; ACQUISITION; ANTIVIRAL; GUIDELINES; RECOMMENDATIONS

Document Type: Research article

Affiliations: 1: Chelsea and Westminster Hospital, London, UK 2: Division of Infectious Diseases and Allergy, Departments of Medicine and Epidemiology, University of Washington, USA 3: Division of Infectious Diseases, University of Minnesota, USA

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$21.33 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A